Outcomes of Women with Early-Stage Breast Cancer Receiving Adjuvant Trastuzumab
Abstract
Share and Cite
Seal, M.D.; Speers, C.H.; O’Reilly, S.; Gelmon, K.A.; Ellard, S.L.; Chia, S.K. Outcomes of Women with Early-Stage Breast Cancer Receiving Adjuvant Trastuzumab. Curr. Oncol. 2012, 19, 197-201. https://doi.org/10.3747/co.19.960
Seal MD, Speers CH, O’Reilly S, Gelmon KA, Ellard SL, Chia SK. Outcomes of Women with Early-Stage Breast Cancer Receiving Adjuvant Trastuzumab. Current Oncology. 2012; 19(4):197-201. https://doi.org/10.3747/co.19.960
Chicago/Turabian StyleSeal, M.D., C.H. Speers, S. O’Reilly, K.A. Gelmon, S.L. Ellard, and S.K. Chia. 2012. "Outcomes of Women with Early-Stage Breast Cancer Receiving Adjuvant Trastuzumab" Current Oncology 19, no. 4: 197-201. https://doi.org/10.3747/co.19.960
APA StyleSeal, M. D., Speers, C. H., O’Reilly, S., Gelmon, K. A., Ellard, S. L., & Chia, S. K. (2012). Outcomes of Women with Early-Stage Breast Cancer Receiving Adjuvant Trastuzumab. Current Oncology, 19(4), 197-201. https://doi.org/10.3747/co.19.960